{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:49:17Z","timestamp":1789534157802,"version":"build-2803163510"},"reference-count":183,"publisher":"Bentham Science Publishers Ltd.","issue":"16","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Viral infections continue to increase morbidity and mortality severely. The flavivirus genus has fifty different species, including the dengue, Zika, and West Nile viruses that can infect 40% of individuals globally, who reside in at least a hundred different countries. Dengue, one of the oldest and most dangerous human infections, was initially documented by the Chinese Medical Encyclopedia in the Jin period. It was referred to as \"water poison,\" connected to flying insects, i.e., Aedes aegypti and Ae-des albopictus. DENV causes some medical expressions like dengue hemorrhagic fever, acute febrile illness, and dengue shock syndrome.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>According to the World Health Organization report of 2012, 2500 million people are in danger of contracting dengue fever worldwide. According to a recent study, 96 million of the 390 million dengue infections yearly show some clinical or subclinical se-verity. There is no antiviral drug or vaccine to treat this severe infection. It can be con-trolled by getting enough rest, drinking plenty of water, and using painkillers. The first dengue vaccine created by Sanofi, called Dengvaxia, was previously approved by the US-FDA in 2019. All four serotypes of the DENV1-4 have shown re-infection in vaccine recipients. However, the usage of Dengvaxia has been constrained by its adverse effects.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Different classes of compounds have been reported against DENV, such as nitrogen-containing heterocycles (i.e., imidazole, pyridine, triazoles quinazolines, quinoline, and indole), oxygen-containing heterocycles (i.e., coumarins), and some are mixed heterocyclic compounds of S, N (thiazole, benzothiazine, and thiazolidinediones), and N, O (i.e., oxadiazole). There have been reports of computationally designed compounds to impede the molecular functions of specific structural and non-structural proteins as potential therapeutic targets. This review summarized the current progress in developing dengue protease inhibitors.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867331666230918110144","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T04:05:42Z","timestamp":1695096342000},"page":"2195-2233","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development in the Inhibition of Dengue Proteases as Drug Targets"],"prefix":"10.2174","volume":"31","author":[{"given":"Muhammad","family":"Akram","sequence":"first","affiliation":[{"name":"Department of Chemistry, Quaid-i-Azam University, Islamabad, 45320, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3341-255X","authenticated-orcid":true,"given":"Shehryar","family":"Hameed","sequence":"additional","affiliation":[{"name":"H.E.J. Research Institute of Chemistry, International Centre for Chemical and Biological Sciences, University of Karachi, Karachi, 75720, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Quaid-i-Azam University, Islamabad, 45320, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid Mohammed","family":"Khan","sequence":"additional","affiliation":[{"name":"H.E.J. Research Institute of Chemistry, International Centre for Chemical and Biological Sciences, University of Karachi, Karachi, 75720, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(14)60629-2","volume":"383","author":"Lancet T.","year":"2014","unstructured":"Lancet T.; Neglected tropical diseases: becoming less neglected. Lancet  2014,383(9925),1269","journal-title":"Lancet"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1371\/journal.pntd.0000247","volume":"2","author":"LaBeaud A.D.","year":"2008","unstructured":"LaBeaud A.D.; Why arboviruses can be neglected tropical diseases. PLoS Negl Trop Dis  2008,2(6),e247","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0188-4409(02)00378-8","volume":"33","author":"Gubler D.J.","year":"2002","unstructured":"Gubler D.J.; The global emergence\/resurgence of arboviral diseases as public health problems. Arch Med Res  2002,33(4),330-342","journal-title":"Arch Med Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1039\/c4md00011k","volume":"5","author":"Burrows J.N.","year":"2014","unstructured":"Burrows J.N.; Elliott R.L.; Kaneko T.; Mowbray C.E.; Waterson D.; The role of modern drug discovery in the fight against neglected and tropical diseases. MedChemComm  2014,5(6),688-700","journal-title":"MedChemComm"},{"key":"ref=5","first-page":"266","volume":"37","author":"Lai P.C.","year":"2004","unstructured":"Lai P.C.; Lee S.S.; Kao C.H.; Chen Y.S.; Huang C-K.; Lin W-R.; Wann S-R.; Lin H.H.; Yen M.Y.; Liu Y.C.; Characteristics of a dengue hemorrhagic fever outbreak in 2001 in Kaohsiung. J Microbiol Immunol Infect  2004,37(5),266-270","journal-title":"J Microbiol Immunol Infect"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0738-081X(89)90034-5","volume":"7","author":"Waterman S.H.","year":"1989","unstructured":"Waterman S.H.; Gubler D.J.; Dengue fever. Clin Dermatol  1989,7(1),117-122","journal-title":"Clin Dermatol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1136\/bmj.324.7353.1563","volume":"324","author":"Gibbons R.V.","year":"2002","unstructured":"Gibbons R.V.; Vaughn D.W.; Dengue: An escalating problem. BMJ  2002,324(7353),1563-1566","journal-title":"BMJ"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/nrmicro2460","volume":"8","author":"Guzman M.G.","year":"2010","unstructured":"Guzman M.G.; Halstead S.B.; Artsob H.; Buchy P.; Farrar J.; Gubler D.J.; Hunsperger E.; Kroeger A.; Margolis H.S.; Mart\u00ednez E.; Nathan M.B.; Pelegrino J.L.; Simmons C.; Yoksan S.; Peeling R.W.; Dengue: A continuing global threat. Nat Rev Microbiol  2010,8(S12)(Suppl.),S7-S16","journal-title":"Nat Rev Microbiol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"113527","DOI":"10.1016\/j.ejmech.2021.113527","volume":"221","author":"Pujar G.V.","year":"2021","unstructured":"Pujar G.V.; Sethu A.K.; Bhagyalalitha M.; Singh M.; Dengue structural proteins as antiviral drug targets: Current status in the drug discovery and development. Eur J Med Chem  2021,221,113527","journal-title":"Eur J Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00018-010-0357-z","volume":"67","author":"Rodenhuis-Zybert I.A.","year":"2010","unstructured":"Rodenhuis-Zybert I.A.; Wilschut J.; Smit J.M.; Dengue virus life cycle: Viral and host factors modulating infectivity. Cell Mol Life Sci  2010,67(16),2773-2786","journal-title":"Cell Mol Life Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.antiviral.2012.09.007","volume":"96","author":"Noble C.G.","year":"2012","unstructured":"Noble C.G.; Shi P.Y.; Structural biology of dengue virus enzymes: Towards rational design of therapeutics. Antiviral Res  2012,96(2),115-126","journal-title":"Antiviral Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e2311","DOI":"10.1371\/journal.pntd.0002311","volume":"7","author":"Santiago G.A.","year":"2013","unstructured":"Santiago G.A.; Vergne E.; Quiles Y.; Cosme J.; Vazquez J.; Medina J.F.; Medina F.; Col\u00f3n C.; Margolis H.; Mu\u00f1oz-Jord\u00e1n J.L.; Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus. PLoS Negl Trop Dis  2013,7(7),e2311","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4269\/ajtmh.2011.10-0521","volume":"84","author":"Beatty M.E.","year":"2011","unstructured":"Beatty M.E.; Margolis H.S.; Coudeville L.; Hutubessy R.; Hombach J.; Dessis D.; Dervaux B.; Wichmann O.; Meltzer M.I.; Kuritsky J.N.; Shepard D.S.; Beutels P.; Health economics of dengue: A systematic literature review and expert panel\u2019s assessment. Am J Trop Med Hyg  2011,84(3),473-488","journal-title":"Am J Trop Med Hyg"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.4269\/ajtmh.2006.75.1113","volume":"75","author":"Alvarez M.","year":"2006","unstructured":"Alvarez M.; Morier L.; Bernardo L.; Halstead S.B.; Guzman M.G.; Castro O.; V\u00e1zquez S.; Gonzalez D.; Rodriguez-Roche R.; Kouri G.; Dengue hemorrhagic fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. Am J Trop Med Hyg  2006,75(6),1113-1117","journal-title":"Am J Trop Med Hyg"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","volume":"60","author":"Halstead S.B.","year":"2003","unstructured":"Halstead S.B.; Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res  2003,60,421-467","journal-title":"Adv Virus Res"},{"key":"ref=16","author":"Kamasa-Quashie D.","year":"2020","unstructured":"Kamasa-Quashie D.;  Relationship between single nucleotide polymorphisms and severe dengue in a Brazilian population  2020","journal-title":"Relationship between single nucleotide polymorphisms and severe dengue in a Brazilian population"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"7061","DOI":"10.1016\/j.vaccine.2015.09.103","volume":"33","author":"Simmons C.P.","year":"2015","unstructured":"Simmons C.P.; McPherson K.; Van Vinh Chau N.; Hoai Tam D.T.; Young P.; Mackenzie J.; Wills B.; Recent advances in dengue pathogenesis and clinical management. Vaccine  2015,33(50),7061-7068","journal-title":"Vaccine"},{"key":"ref=18","first-page":"349","volume":"91","author":"Organization W.H.","year":"2016","unstructured":"Organization W.H.; Dengue vaccine: WHO position paper \u2013 July 2016. Wkly Epidemiol Rec  2016,91(30),349-364","journal-title":"Wkly Epidemiol Rec"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1021\/cr950025u","volume":"97","author":"Otto H.H.","year":"1997","unstructured":"Otto H.H.; Schirmeister T.; Cysteine proteases and their inhibitors. Chem Rev  1997,97(1),133-172","journal-title":"Chem Rev"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2174\/138161207780162962","volume":"13","author":"Vasiljeva O.","year":"2007","unstructured":"Vasiljeva O.; Reinheckel T.; Peters C.; Turk D.; Turk V.; Turk B.; Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr Pharm Des  2007,13(4),387-403","journal-title":"Curr Pharm Des"},{"key":"ref=21","doi-asserted-by":"crossref","DOI":"10.1002\/9781119117599","author":"Walsh G.","year":"2015","unstructured":"Walsh G.;  Proteins: Biochemistry and Biotechnology  2015","journal-title":"Proteins: Biochemistry and Biotechnology"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev.biophys.28.1.181","volume":"28","author":"McGrath M.E.","year":"1999","unstructured":"McGrath M.E.; The lysosomal cysteine proteases. Annu Rev Biophys Biomol Struct  1999,28(1),181-204","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0895-7061(99)00236-8","volume":"13","author":"Petrov V.","year":"2000","unstructured":"Petrov V.; Fagard R.; Lijnen P.; Effect of protease inhibitors on angiotensin-converting enzyme activity in human T-lymphocytes. Am J Hypertens  2000,13(5),535-539","journal-title":"Am J Hypertens"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.4049\/jimmunol.1200901","volume":"190","author":"Hirai T.","year":"2013","unstructured":"Hirai T.; Kanda T.; Sato K.; Takaishi M.; Nakajima K.; Yamamoto M.; Kamijima R.; DiGiovanni J.; Sano S.; Cathepsin K is involved in development of psoriasis-like skin lesions through TLR-dependent Th17 activation. J Immunol  2013,190(9),4805-4811","journal-title":"J Immunol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-6851(01)00438-8","volume":"120","author":"Sajid M.","year":"2002","unstructured":"Sajid M.; McKerrow J.H.; Cysteine proteases of parasitic organisms. Mol Biochem Parasitol  2002,120(1),1-21","journal-title":"Mol Biochem Parasitol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","volume":"44","author":"Chambers T.J.","year":"1990","unstructured":"Chambers T.J.; Hahn C.S.; Galler R.; Rice C.M.; Flavivirus genome organization, expression, and replication. Annu Rev Microbiol  1990,44(1),649-688","journal-title":"Annu Rev Microbiol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"11418","DOI":"10.1128\/JVI.01257-06","volume":"80","author":"Clyde K.","year":"2006","unstructured":"Clyde K.; Kyle J.L.; Harris E.; Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol  2006,80(23),11418-11431","journal-title":"J Virol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"8475","DOI":"10.1128\/jvi.71.11.8475-8481.1997","volume":"71","author":"Stadler K.","year":"1997","unstructured":"Stadler K.; Allison S.L.; Schalich J.; Heinz F.X.; Proteolytic activation of tick-borne encephalitis virus by furin. J Virol  1997,71(11),8475-8481","journal-title":"J Virol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1007\/s00253-018-8822-y","volume":"102","author":"Fahimi H.","year":"2018","unstructured":"Fahimi H.; Mohammadipour M.; Haddad Kashani H.; Parvini F.; Sadeghizadeh M.; Dengue viruses and promising envelope protein domain III-based vaccines. Appl Microbiol Biotechnol  2018,102(7),2977-2996","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature02165","volume":"427","author":"Modis Y.","year":"2004","unstructured":"Modis Y.; Ogata S.; Clements D.; Harrison S.C.; Structure of the dengue virus envelope protein after membrane fusion. Nature  2004,427(6972),313-319","journal-title":"Nature"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-virology-110615-042334","volume":"3","author":"Byk L.A.","year":"2016","unstructured":"Byk L.A.; Gamarnik A.V.; Properties and functions of the dengue virus capsid protein. Annu Rev Virol  2016,3(1),263-281","journal-title":"Annu Rev Virol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.antiviral.2018.04.019","volume":"155","author":"Smith J.L.","year":"2018","unstructured":"Smith J.L.; Sheridan K.; Parkins C.J.; Frueh L.; Jemison A.L.; Strode K.; Dow G.; Nilsen A.; Hirsch A.J.; Characterization and structure-activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virions. Antiviral Res  2018,155,12-19","journal-title":"Antiviral Res"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/420867","volume":"2015","author":"Yeo A.S.L.","year":"2015","unstructured":"Yeo A.S.L.; Rathakrishnan A.; Wang S.M.; Ponnampalavanar S.; Manikam R.; Sathar J.; Kumari Natkunam S.; Sekaran S.D.; Dengue patients exhibit higher levels of PrM and E antibodies than their asymptomatic counterparts. BioMed Res Int  2015,2015,1-10","journal-title":"BioMed Res Int"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"33149","DOI":"10.1074\/jbc.M114.610428","volume":"289","author":"Hsieh S.C.","year":"2014","unstructured":"Hsieh S.C.; Wu Y.C.; Zou G.; Nerurkar V.R.; Shi P.Y.; Wang W.K.; Highly conserved residues in the helical domain of dengue virus type 1 precursor membrane protein are involved in assembly, precursor membrane (prM) protein cleavage, and entry. J Biol Chem  2014,289(48),33149-33160","journal-title":"J Biol Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/sj.embor.embor866","volume":"4","author":"Navarro-Sanchez E.","year":"2003","unstructured":"Navarro-Sanchez E.; Altmeyer R.; Amara A.; Schwartz O.; Fieschi F.; Virelizier J.L.; Arenzana-Seisdedos F.; Despr\u00e8s P.; Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito\u2010cell-derived dengue viruses. EMBO Rep  2003,4(7),723-728","journal-title":"EMBO Rep"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.antiviral.2009.12.011","volume":"85","author":"Noble C.G.","year":"2010","unstructured":"Noble C.G.; Chen Y.L.; Dong H.; Gu F.; Lim S.P.; Schul W.; Wang Q.Y.; Shi P.Y.; Strategies for development of dengue virus inhibitors. Antiviral Res  2010,85(3),450-462","journal-title":"Antiviral Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrmicro1067","volume":"3","author":"Mukhopadhyay S.","year":"2005","unstructured":"Mukhopadhyay S.; Kuhn R.J.; Rossmann M.G.; A structural perspective of the flavivirus life cycle. Nat Rev Microbiol  2005,3(1),13-22","journal-title":"Nat Rev Microbiol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/AAC.01148-08","volume":"53","author":"Wang Q.Y.","year":"2009","unstructured":"Wang Q.Y.; Patel S.J.; Vangrevelinghe E.; Xu H.Y.; Rao R.; Jaber D.; Schul W.; Gu F.; Heudi O.; Ma N.L.; Poh M.K.; Phong W.Y.; Keller T.H.; Jacoby E.; Vasudevan S.G.; A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother  2009,53(5),1823-1831","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.antiviral.2009.09.011","volume":"84","author":"Poh M.K.","year":"2009","unstructured":"Poh M.K.; Yip A.; Zhang S.; Priestle J.P.; Ma N.L.; Smit J.M.; Wilschut J.; Shi P.Y.; Wenk M.R.; Schul W.; A small molecule fusion inhibitor of dengue virus. Antiviral Res  2009,84(3),260-266","journal-title":"Antiviral Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1021\/cb800176t","volume":"3","author":"Zhou Z.","year":"2008","unstructured":"Zhou Z.; Khaliq M.; Suk J.E.; Patkar C.; Li L.; Kuhn R.J.; Post C.B.; Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein. ACS Chem Biol  2008,3(12),765-775","journal-title":"ACS Chem Biol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.antiviral.2009.09.007","volume":"84","author":"Kampmann T.","year":"2009","unstructured":"Kampmann T.; Yennamalli R.; Campbell P.; Stoermer M.J.; Fairlie D.P.; Kobe B.; Young P.R.; In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Antiviral Res  2009,84(3),234-241","journal-title":"Antiviral Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"e1007553","DOI":"10.1371\/journal.ppat.1007553","volume":"15","author":"Schmidt A.G.","year":"2019","unstructured":"Schmidt A.G.; Lee K.; Yang P.L.; Harrison S.C.; Correction: Small-molecule inhibitors of dengue-virus entry. PLoS Pathog  2019,15(1),e1007553","journal-title":"PLoS Pathog"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"e721","DOI":"10.1371\/journal.pntd.0000721","volume":"4","author":"Costin J.M.","year":"2010","unstructured":"Costin J.M.; Jenwitheesuk E.; Lok S.M.; Hunsperger E.; Conrads K.A.; Fontaine K.A.; Rees C.R.; Rossmann M.G.; Isern S.; Samudrala R.; Michael S.F.; Structural optimization and de novo design of dengue virus entry inhibitory peptides. PLoS Negl Trop Dis  2010,4(6),e721","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-2-1","volume":"2","author":"Hrobowski Y.M.","year":"2005","unstructured":"Hrobowski Y.M.; Garry R.F.; Michael S.F.; The involvement of survival signaling pathways in rubella-virus induced apoptosis. Virol J  2005,2(1),1-10","journal-title":"Virol J"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"6986","DOI":"10.1073\/pnas.0832193100","volume":"100","author":"Modis Y.","year":"2003","unstructured":"Modis Y.; Ogata S.; Clements D.; Harrison S.C.; A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA  2003,100(12),6986-6991","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.antiviral.2013.09.013","volume":"100","author":"Lim S.P.","year":"2013","unstructured":"Lim S.P.; Wang Q.Y.; Noble C.G.; Chen Y.L.; Dong H.; Zou B.; Yokokawa F.; Nilar S.; Smith P.; Beer D.; Lescar J.; Shi P.Y.; Ten years of dengue drug discovery: Progress and prospects. Antiviral Res  2013,100(2),500-519","journal-title":"Antiviral Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"719","DOI":"10.7150\/ijms.5037","volume":"10","author":"Alhoot M.A.","year":"2013","unstructured":"Alhoot M.A.; Rathinam A.K.; Wang S.M.; Manikam R.; Sekaran S.D.; Inhibition of dengue virus entry into target cells using synthetic antiviral peptides. Int J Med Sci  2013,10(6),719-729","journal-title":"Int J Med Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.bmcl.2015.02.059","volume":"25","author":"Jadav S.S.","year":"2015","unstructured":"Jadav S.S.; Kaptein S.; Timiri A.; De Burghgraeve T.; Badavath V.N.; Ganesan R.; Sinha B.N.; Neyts J.; Leyssen P.; Jayaprakash V.; Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors. Bioorg Med Chem Lett  2015,25(8),1747-1752","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.antiviral.2017.11.005","volume":"149","author":"Lin C.","year":"2018","unstructured":"Lin C.; Yu J.; Hussain M.; Zhou Y.; Duan A.; Pan W.; Yuan J.; Zhang J.; Design, synthesis, and biological evaluation of novel 7-deazapurine nucleoside derivatives as potential anti-dengue virus agents. Antiviral Res  2018,149,95-105","journal-title":"Antiviral Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e1000632","DOI":"10.1371\/journal.ppat.1000632","volume":"5","author":"Samsa M.M.","year":"2009","unstructured":"Samsa M.M.; Mondotte J.A.; Iglesias N.G.; Assun\u00e7\u00e3o-Miranda I.; Barbosa-Lima G.; Da Poian A.T.; Bozza P.T.; Gamarnik A.V.; Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog  2009,5(10),e1000632","journal-title":"PLoS Pathog"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1128\/AAC.01429-12","volume":"57","author":"Byrd C.M.","year":"2013","unstructured":"Byrd C.M.; Dai D.; Grosenbach D.W.; Berhanu A.; Jones K.F.; Cardwell K.B.; Schneider C.; Wineinger K.A.; Page J.M.; Harver C.; Stavale E.; Tyavanagimatt S.; Stone M.A.; Bartenschlager R.; Scaturro P.; Hruby D.E.; Jordan R.; A novel inhibitor of dengue virus replication that targets the capsid protein. Antimicrob Agents Chemother  2013,57(1),15-25","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2015.01.002","volume":"116","author":"Lee J.C.","year":"2015","unstructured":"Lee J.C.; Tseng C.K.; Wu Y.H.; Kaushik-Basu N.; Lin C.K.; Chen W.C.; Wu H.N.; Characterization of the activity of 2\u2032-C-methylcytidine against dengue virus replication. Antiviral Res  2015,116,1-9","journal-title":"Antiviral Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.antiviral.2017.03.026","volume":"143","author":"Peng M.","year":"2017","unstructured":"Peng M.; Watanabe S.; Chan K.W.K.; He Q.; Zhao Y.; Zhang Z.; Lai X.; Luo D.; Vasudevan S.G.; Li G.; Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin. Antiviral Res  2017,143,176-185","journal-title":"Antiviral Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.virol.2016.06.008","volume":"496","author":"Alayli F.","year":"2016","unstructured":"Alayli F.; Scholle F.; Dengue virus NS1 enhances viral replication and pro-inflammatory cytokine production in human dendritic cells. Virology  2016,496,227-236","journal-title":"Virology"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1128\/JVI.73.6.4611-4621.1999","volume":"73","author":"Lindenbach B.D.","year":"1999","unstructured":"Lindenbach B.D.; Rice C.M.; Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. J Virol  1999,73(6),4611-4621","journal-title":"J Virol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.vaccine.2005.11.002","volume":"24","author":"Konishi E.","year":"2006","unstructured":"Konishi E.; Kosugi S.; Imoto J.; Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice. Vaccine  2006,24(12),2200-2207","journal-title":"Vaccine"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/jvi.65.4.1823-1828.1991","volume":"65","author":"Kurane I.","year":"1991","unstructured":"Kurane I.; Brinton M.A.; Samson A.L.; Ennis F.A.; Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: Multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J Virol  1991,65(4),1823-1828","journal-title":"J Virol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1016\/j.vaccine.2015.09.102","volume":"33","author":"Porter K.R.","year":"2015","unstructured":"Porter K.R.; Raviprakash K.; Nucleic acid (DNA) immunization as a platform for dengue vaccine development. Vaccine  2015,33(50),7135-7140","journal-title":"Vaccine"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2180-14-140","volume":"14","author":"Rothan H.A.","year":"2014","unstructured":"Rothan H.A.; Bahrani H.; Rahman N.; Yusof R.; Identification of natural antimicrobial agents to treat dengue infection: In vitro analysis of latarcin peptide activity against dengue virus. BMC Microbiol  2014,14(1),140","journal-title":"BMC Microbiol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/0959-440X(95)80051-4","volume":"5","author":"Jacob G.S.","year":"1995","unstructured":"Jacob G.S.; Glycosylation inhibitors in biology and medicine. Curr Opin Struct Biol  1995,5(5),605-611","journal-title":"Curr Opin Struct Biol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1096\/fasebj.5.15.1743438","volume":"5","author":"Elbein A.D.","year":"1991","unstructured":"Elbein A.D.; Glycosidase inhibitors: inhibitors of N\u2010linked oligosaccharide processing. FASEB J  1991,5(15),3055-3063","journal-title":"FASEB J"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1021\/bi00285a038","volume":"22","author":"Pan Y.T.","year":"1983","unstructured":"Pan Y.T.; Hori H.; Saul R.; Sanford B.A.; Molyneux R.J.; Elbein A.D.; Castanospermine inhibits the processing of the oligosaccharide portion of the influenza viral hemagglutinin. Biochemistry  1983,22(16),3975-3984","journal-title":"Biochemistry"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nm0598-610","volume":"4","author":"Block T.M.","year":"1998","unstructured":"Block T.M.; Lu X.; Mehta A.S.; Blumberg B.S.; Tennant B.; Ebling M.; Korba B.; Lansky D.M.; Jacob G.S.; Dwek R.A.; Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. Nat Med  1998,4(5),610-614","journal-title":"Nat Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1128\/JVI.74.1.564-572.2000","volume":"74","author":"Courageot M.P.","year":"2000","unstructured":"Courageot M.P.; Frenkiel M.P.; Duarte Dos Santos C.; Deubel V.; Despr\u00e8s P.; Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum. J Virol  2000,74(1),564-572","journal-title":"J Virol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1086\/511310","volume":"195","author":"Schul W.","year":"2007","unstructured":"Schul W.; Liu W.; Xu H.Y.; Flamand M.; Vasudevan S.G.; A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J Infect Dis  2007,195(5),665-674","journal-title":"J Infect Dis"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"14504","DOI":"10.1016\/S0021-9258(18)98715-6","volume":"266","author":"Tan A.","year":"1991","unstructured":"Tan A.; van den Broek L.; van Boeckel S.; Ploegh H.; Bolscher J.; Chemical modification of the glucosidase inhibitor 1-deoxynojirimycin. Structure-activity relationships. J Biol Chem  1991,266(22),14504-14510","journal-title":"J Biol Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1042\/bj20020466","volume":"366","author":"Mellor H.R.","year":"2002","unstructured":"Mellor H.R.; Nolan J.; Pickering L.; Wormald M.R.; Platt F.M.; Dwek R.A.; Fleet G.W.J.; Butters T.D.; Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycins. Biochem J  2002,366(1),225-233","journal-title":"Biochem J"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.antiviral.2011.10.002","volume":"92","author":"Rathore A.P.S.","year":"2011","unstructured":"Rathore A.P.S.; Paradkar P.N.; Watanabe S.; Tan K.H.; Sung C.; Connolly J.E.; Low J.; Ooi E.E.; Vasudevan S.G.; Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model. Antiviral Res  2011,92(3),453-460","journal-title":"Antiviral Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-014-0235-7","volume":"12","author":"Raut R.","year":"2015","unstructured":"Raut R.; Beesetti H.; Tyagi P.; Khanna I.; Jain S.K.; Jeankumar V.U.; Yogeeswari P.; Sriram D.; Swaminathan S.; Complete genome sequencing and phylogenetic analysis of dengue type 1 virus isolated from Jeddah, Saudi Arabia. J Virol  2015,12(1),1-7","journal-title":"J Virol"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.chom.2019.09.015","volume":"26","author":"Xie X.","year":"2019","unstructured":"Xie X.; Zou J.; Zhang X.; Zhou Y.; Routh A.L.; Kang C.; Popov V.L.; Chen X.; Wang Q-Y.; Dong H.; Dengue NS2A protein orchestrates virus assembly. Cell Host Microbe  2019,26(5),606-622","journal-title":"Cell Host Microbe"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"10142","DOI":"10.1021\/jp504911r","volume":"118","author":"Nem\u00e9sio H.","year":"2014","unstructured":"Nem\u00e9sio H.; Villala\u00edn J.; Membrane interacting regions of Dengue virus NS2A protein. J Phys Chem B  2014,118(34),10142-10155","journal-title":"J Phys Chem B"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.bbamem.2015.06.010","volume":"1848","author":"Li Y.","year":"2015","unstructured":"Li Y.; Li Q.; Wong Y.L.; Liew L.S.Y.; Kang C.; Membrane topology of NS2B of dengue virus revealed by NMR spectroscopy. Biochim Biophys Acta Biomembr  2015,1848(10),2244-2252","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"12891","DOI":"10.1074\/jbc.M112.442723","volume":"288","author":"Kim Y.M.","year":"2013","unstructured":"Kim Y.M.; Gayen S.; Kang C.; Joy J.; Huang Q.; Chen A.S.; Wee J.L.K.; Ang M.J.Y.; Lim H.A.; Hung A.W.; Li R.; Noble C.G.; Lee L.T.; Yip A.; Wang Q.Y.; Chia C.S.B.; Hill J.; Shi P.Y.; Keller T.H.; NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complex. J Biol Chem  2013,288(18),12891-12900","journal-title":"J Biol Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"e0210869","DOI":"10.1371\/journal.pone.0210869","volume":"14","author":"Hariono M.","year":"2019","unstructured":"Hariono M.; Choi S.B.; Roslim R.F.; Nawi M.S.; Tan M.L.; Kamarulzaman E.E.; Mohamed N.; Yusof R.; Othman S.; Abd Rahman N.; Othman R.; Wahab H.A.; Thioguanine-based DENV-2 NS2B\/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling. PLoS One  2019,14(1),e0210869","journal-title":"PLoS One"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/AAC.00855-10","volume":"55","author":"Yang C.C.","year":"2011","unstructured":"Yang C.C.; Hsieh Y.C.; Lee S.J.; Wu S.H.; Liao C.L.; Tsao C.H.; Chao Y.S.; Chern J.H.; Wu C.P.; Yueh A.; Novel dengue virus-specific NS2B\/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay. Antimicrob Agents Chemother  2011,55(1),229-238","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bioorg.2015.07.005","volume":"62","author":"Timiri A.K.","year":"2015","unstructured":"Timiri A.K.; Selvarasu S.; Kesherwani M.; Vijayan V.; Sinha B.N.; Devadasan V.; Jayaprakash V.; Synthesis and molecular modelling studies of novel sulphonamide derivatives as dengue virus 2 protease inhibitors. Bioorg Chem  2015,62,74-82","journal-title":"Bioorg Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/aps.2015.56","volume":"36","author":"Wu D.","year":"2015","unstructured":"Wu D.; Mao F.; Ye Y.; Li J.; Xu C.; Luo X.; Chen J.; Shen X.; Policresulen, a novel NS2B\/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells. Acta Pharmacol Sin  2015,36(9),1126-1136","journal-title":"Acta Pharmacol Sin"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.apsb.2017.04.009","volume":"7","author":"Osman H.","year":"2017","unstructured":"Osman H.; Idris N.H.; Kamarulzaman E.E.; Wahab H.A.; Hassan M.Z.; 3,5-Bis(arylidene)-4-piperidones as potential dengue protease inhibitors. Acta Pharm Sin B  2017,7(4),479-484","journal-title":"Acta Pharm Sin B"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ejmech.2016.09.063","volume":"125","author":"Weng Z.","year":"2017","unstructured":"Weng Z.; Shao X.; Graf D.; Wang C.; Klein C.D.; Wang J.; Zhou G.C.; Identification of fused bicyclic derivatives of pyrrolidine and imidazolidinone as dengue virus-2 NS2B-NS3 protease inhibitors. Eur J Med Chem  2017,125,751-759","journal-title":"Eur J Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"103567","DOI":"10.1016\/j.bioorg.2020.103567","volume":"96","author":"Hamdani S.S.","year":"2020","unstructured":"Hamdani S.S.; Khan B.A.; Hameed S.; Batool F.; Saleem H.N.; Mughal E.U.; Saeed M.; Synthesis and evaluation of novel S-benzyl- and S-alkylphthalimide-oxadiazole-benzenesulfonamide hybrids as inhibitors of dengue virus protease. Bioorg Chem  2020,96,103567","journal-title":"Bioorg Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1016\/j.bmc.2011.05.015","volume":"19","author":"Steuer C.","year":"2011","unstructured":"Steuer C.; Gege C.; Fischl W.; Heinonen K.H.; Bartenschlager R.; Klein C.D.; Synthesis and biological evaluation of \u03b1-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture. Bioorg Med Chem  2011,19(13),4067-4074","journal-title":"Bioorg Med Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bmc.2012.10.058","volume":"21","author":"Lai H.","year":"2013","unstructured":"Lai H.; Dou D.; Aravapalli S.; Teramoto T.; Lushington G.H.; Mwania T.M.; Alliston K.R.; Eichhorn D.M.; Padmanabhan R.; Groutas W.C.; Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)-one and 1,3,4-oxadiazole hybrid derivatives: Potent inhibitors of Dengue and West Nile virus NS2B\/NS3 proteases. Bioorg Med Chem  2013,21(1),102-113","journal-title":"Bioorg Med Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.antiviral.2012.10.009","volume":"97","author":"Lai H.","year":"2013","unstructured":"Lai H.; Sridhar Prasad G.; Padmanabhan R.; Characterization of 8-hydroxyquinoline derivatives containing aminobenzothiazole as inhibitors of dengue virus type 2 protease in vitro. Antiviral Res  2013,97(1),74-80","journal-title":"Antiviral Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"9354","DOI":"10.1021\/acs.jmedchem.5b01441","volume":"58","author":"Behnam M.A.M.","year":"2015","unstructured":"Behnam M.A.M.; Graf D.; Bartenschlager R.; Zlotos D.P.; Klein C.D.; Discovery of nanomolar dengue and west nile virus protease inhibitors containing a 4-benzyloxyphenylglycine residue. J Med Chem  2015,58(23),9354-9370","journal-title":"J Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"8389","DOI":"10.1021\/jm400828u","volume":"56","author":"Nitsche C.","year":"2013","unstructured":"Nitsche C.; Schreier V.N.; Behnam M.A.M.; Kumar A.; Bartenschlager R.; Klein C.D.; Thiazolidinone-peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture. J Med Chem  2013,56(21),8389-8403","journal-title":"J Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1016\/j.bmc.2014.09.057","volume":"22","author":"Liu H.","year":"2014","unstructured":"Liu H.; Wu R.; Sun Y.; Ye Y.; Chen J.; Luo X.; Shen X.; Liu H.; Identification of novel thiadiazoloacrylamide analogues as inhibitors of dengue-2 virus NS2B\/NS3 protease. Bioorg Med Chem  2014,22(22),6344-6352","journal-title":"Bioorg Med Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.bmc.2009.12.026","volume":"18","author":"Gao Y.","year":"2010","unstructured":"Gao Y.; Cui T.; Lam Y.; Synthesis and disulfide bond connectivity\u2013activity studies of a kalata B1-inspired cyclopeptide against dengue NS2B\u2013NS3 protease. Bioorg Med Chem  2010,18(3),1331-1336","journal-title":"Bioorg Med Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.bbrc.2013.03.139","volume":"434","author":"Prusis P.","year":"2013","unstructured":"Prusis P.; Junaid M.; Petrovska R.; Yahorava S.; Yahorau A.; Katzenmeier G.; Lapins M.; Wikberg J.E.S.; Design and evaluation of substrate-based octapeptide and non substrate-based tetrapeptide inhibitors of dengue virus NS2B\u2013NS3 proteases. Biochem Biophys Res Commun  2013,434(4),767-772","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1021\/acs.jmedchem.5b00612","volume":"58","author":"Weigel L.F.","year":"2015","unstructured":"Weigel L.F.; Nitsche C.; Graf D.; Bartenschlager R.; Klein C.D.; Phenylalanine and phenylglycine analogues as arginine mimetics in dengue protease inhibitors. J Med Chem  2015,58(19),7719-7733","journal-title":"J Med Chem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1006\/viro.1993.1198","volume":"193","author":"Arias C.F.","year":"1993","unstructured":"Arias C.F.; Preugschat F.; Strauss J.H.; Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain. Virology  1993,193(2),888-899","journal-title":"Virology"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1128\/jvi.65.5.2467-2475.1991","volume":"65","author":"Falgout B.","year":"1991","unstructured":"Falgout B.; Pethel M.; Zhang Y.M.; Lai C.J.; Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol  1991,65(5),2467-2475","journal-title":"J Virol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1128\/jvi.67.4.2034-2042.1993","volume":"67","author":"Falgout B.","year":"1993","unstructured":"Falgout B.; Miller R.H.; Lai C.J.; Deletion analysis of dengue virus type 4 nonstructural protein NS2B: Identification of a domain required for NS2B-NS3 protease activity. J Virol  1993,67(4),2034-2042","journal-title":"J Virol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1128\/JVI.73.4.3108-3116.1999","volume":"73","author":"Li H.","year":"1999","unstructured":"Li H.; Clum S.; You S.; Ebner K.E.; Padmanabhan R.; The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. J Virol  1999,73(4),3108-3116","journal-title":"J Virol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"9963","DOI":"10.1074\/jbc.275.14.9963","volume":"275","author":"Yusof R.","year":"2000","unstructured":"Yusof R.; Clum S.; Wetzel M.; Murthy H.M.K.; Padmanabhan R.; Purified NS2B\/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J Biol Chem  2000,275(14),9963-9969","journal-title":"J Biol Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"45762","DOI":"10.1074\/jbc.M107360200","volume":"276","author":"Leung D.","year":"2001","unstructured":"Leung D.; Schroder K.; White H.; Fang N.X.; Stoermer M.J.; Abbenante G.; Martin J.L.; Young P.R.; Fairlie D.P.; Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J Biol Chem  2001,276(49),45762-45771","journal-title":"J Biol Chem"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"28766","DOI":"10.1074\/jbc.M500588200","volume":"280","author":"Li J.","year":"2005","unstructured":"Li J.; Lim S.P.; Beer D.; Patel V.; Wen D.; Tumanut C.; Tully D.C.; Williams J.A.; Jiricek J.; Priestle J.P.; Harris J.L.; Vasudevan S.G.; Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries. J Biol Chem  2005,280(31),28766-28774","journal-title":"J Biol Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.1074\/jbc.274.9.5573","volume":"274","author":"Murthy H.M.K.","year":"1999","unstructured":"Murthy H.M.K.; Clum S.; Padmanabhan R.; Dengue virus NS3 serine protease. Crystal structure and insights into interaction of the active site with substrates by molecular modeling and structural analysis of mutational effects. J Biol Chem  1999,274(9),5573-5580","journal-title":"J Biol Chem"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2174\/138161206776361110","volume":"12","author":"Hsu J.","year":"2006","unstructured":"Hsu J.; Wang H.C.; Chen G.W.; Shih S.R.; Antiviral drug discovery targeting to viral proteases. Curr Pharm Des  2006,12(11),1301-1314","journal-title":"Curr Pharm Des"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.antiviral.2009.07.006","volume":"85","author":"Men\u00e9ndez-Arias L.","year":"2010","unstructured":"Men\u00e9ndez-Arias L.; Molecular basis of human immunodeficiency virus drug resistance: An update. Antiviral Res  2010,85(1),210-231","journal-title":"Antiviral Res"},{"key":"ref=100","first-page":"1","volume":"6","author":"Wendt A.","year":"2014","unstructured":"Wendt A.; Adhoute X.; Castellani P.; Oules V.; Ansaldi C.; Benali S.; Bourli\u00e8re M.; Chronic hepatitis C: Future treatment. Clin Pharmacol  2014,6,1-17","journal-title":"Clin Pharmacol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1590\/S1415-47572010000200002","volume":"33","author":"Natarajan S.","year":"2010","unstructured":"Natarajan S.; NS3 protease from flavivirus as a target for designing antiviral inhibitors against dengue virus. Genet Mol Biol  2010,33(2),214-219","journal-title":"Genet Mol Biol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0042-6822(89)90639-9","volume":"171","author":"Bazan J.F.","year":"1989","unstructured":"Bazan J.F.; Fletterick R.J.; Detection of a trypsin-like serine protease domain in flaviviruses and pestviruses. Virology  1989,171(2),637-639","journal-title":"Virology"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nsmb1073","volume":"13","author":"Erbel P.","year":"2006","unstructured":"Erbel P.; Schiering N.; D\u2019Arcy A.; Renatus M.; Kroemer M.; Lim S.P.; Yin Z.; Keller T.H.; Vasudevan S.G.; Hommel U.; Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol  2006,13(4),372-373","journal-title":"Nat Struct Mol Biol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1128\/AAC.01508-07","volume":"52","author":"Mueller N.H.","year":"2008","unstructured":"Mueller N.H.; Pattabiraman N.; Ansarah-Sobrinho C.; Viswanathan P.; Pierson T.C.; Padmanabhan R.; Identification and biochemical characterization of small-molecule inhibitors of west nile virus serine protease by a high-throughput screen. Antimicrob Agents Chemother  2008,52(9),3385-3393","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.antiviral.2015.04.010","volume":"119","author":"Lim S.P.","year":"2015","unstructured":"Lim S.P.; Noble C.G.; Shi P.Y.; The dengue virus NS5 protein as a target for drug discovery. Antiviral Res  2015,119,57-67","journal-title":"Antiviral Res"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2015.03.007","volume":"118","author":"Xie X.","year":"2015","unstructured":"Xie X.; Zou J.; Wang Q.Y.; Shi P.Y.; Targeting dengue virus NS4B protein for drug discovery. Antiviral Res  2015,118,39-45","journal-title":"Antiviral Res"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/md14080151","volume":"14","author":"Lee J.C.","year":"2016","unstructured":"Lee J.C.; Chang F.R.; Chen S.R.; Wu Y.H.; Hu H.C.; Wu Y.C.; Backlund A.; Cheng Y.B.; Anti-dengue virus constituents from formosan zoanthid palythoa mutuki. Mar Drugs  2016,14(8),151","journal-title":"Mar Drugs"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"6746","DOI":"10.1128\/JVI.00423-15","volume":"89","author":"Naik N.G.","year":"2015","unstructured":"Naik N.G.; Wu H.N.; Mutation of putative N-glycosylation sites on dengue virus NS4B decreases RNA replication. J Virol  2015,89(13),6746-6760","journal-title":"J Virol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1128\/AAC.03543-14","volume":"59","author":"Wu H.","year":"2015","unstructured":"Wu H.; Bock S.; Snitko M.; Berger T.; Weidner T.; Holloway S.; Kanitz M.; Diederich W.E.; Steuber H.; Walter C.; Hofmann D.; Wei\u00dfbrich B.; Spannaus R.; Acosta E.G.; Bartenschlager R.; Engels B.; Schirmeister T.; Bodem J.; Novel dengue virus NS2B\/NS3 protease inhibitors. Antimicrob Agents Chemother  2015,59(2),1100-1109","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1128\/AAC.01281-13","volume":"58","author":"Yang C.C.","year":"2014","unstructured":"Yang C.C.; Hu H.S.; Wu R.H.; Wu S.H.; Lee S.J.; Jiaang W.T.; Chern J.H.; Huang Z.S.; Wu H.N.; Chang C.M.; Yueh A.; A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B\/NS3 protease. Antimicrob Agents Chemother  2014,58(1),110-119","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.antiviral.2016.08.014","volume":"134","author":"Balasubramanian A.","year":"2016","unstructured":"Balasubramanian A.; Manzano M.; Teramoto T.; Pilankatta R.; Padmanabhan R.; High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease. Antiviral Res  2016,134,6-16","journal-title":"Antiviral Res"},{"key":"ref=112","first-page":"270","volume":"34","author":"Gan C.S.","year":"2017","unstructured":"Gan C.S.; Lee Y.K.; Heh C.H.; Rahman N.A.; Yusof R.; Othman S.; The synthetic molecules YK51 and YK73 attenuate replication of dengue virus serotype 2. Trop Biomed  2017,34(2),270-283","journal-title":"Trop Biomed"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actatropica.2018.08.022","volume":"188","author":"Padmapriya P.","year":"2018","unstructured":"Padmapriya P.; Gracy Fathima S.; Ramanathan G.; v, Y.; A, K.S.; Kaveri, K.; Gunasekaran, P.; Tirichurapalli Sivagnanam, U.; Thennarasu, S. Development of antiviral inhibitor against dengue 2 targeting Ns3 protein: In vitro and in silico significant studies. Acta Trop  2018,188,1-8","journal-title":"Acta Trop"},{"key":"ref=114","first-page":"255","volume":"86","author":"Li L.","year":"2015","unstructured":"Li L.; Basavannacharya C.; Chan K.W.K.; Shang L.; Vasudevan S.G.; Yin Z.; Structure-guided discovery of a novel non-peptide inhibitor of dengue virus NS2B-NS3 protease. Eur J Med Chem  2015,86,255-264","journal-title":"Eur J Med Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1080\/14756366.2017.1355791","volume":"32","author":"Pelliccia S.","year":"2017","unstructured":"Pelliccia S.; Wu Y.H.; Coluccia A.; La Regina G.; Tseng C.K.; Famiglini V.; Masci D.; Hiscott J.; Lee J.C.; Silvestri R.; Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities. J Enzyme Inhib Med Chem  2017,32(1),1091-1101","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"8873","DOI":"10.1074\/jbc.M609919200","volume":"282","author":"Miller S.","year":"2007","unstructured":"Miller S.; Kastner S.; Krijnse-Locker J.; B\u00fchler S.; Bartenschlager R.; The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner. J Biol Chem  2007,282(12),8873-8882","journal-title":"J Biol Chem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.bbamem.2017.10.016","volume":"1860","author":"Li Y.","year":"2018","unstructured":"Li Y.; Lee M.Y.; Loh Y.R.; Kang C.; Secondary structure and membrane topology of dengue virus NS4A protein in micelles. Biochim Biophys Acta Biomembr  2018,1860(2),442-450","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.3390\/v7072812","volume":"7","author":"Hung Y.F.","year":"2015","unstructured":"Hung Y.F.; Schwarten M.; Hoffmann S.; Willbold D.; Sklan E.; Koenig B.; Amino terminal region of dengue virus NS4A cytosolic domain binds to highly curved liposomes. Viruses  2015,7(7),4119-4130","journal-title":"Viruses"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1128\/JVI.01900-12","volume":"87","author":"Stern O.","year":"2013","unstructured":"Stern O.; Hung Y.F.; Valdau O.; Yaffe Y.; Harris E.; Hoffmann S.; Willbold D.; Sklan E.H.; An N-terminal amphipathic helix in dengue virus nonstructural protein 4A mediates oligomerization and is essential for replication. J Virol  2013,87(7),4080-4085","journal-title":"J Virol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1128\/JVI.00546-15","volume":"89","author":"Lee C.M.","year":"2015","unstructured":"Lee C.M.; Xie X.; Zou J.; Li S.H.; Lee M.Y.Q.; Dong H.; Qin C.F.; Kang C.; Shi P.Y.; Determinants of dengue virus NS4A protein oligomerization. J Virol  2015,89(12),6171-6183","journal-title":"J Virol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1128\/JVI.03453-14","volume":"89","author":"Zou J.","year":"2015","unstructured":"Zou J.; Xie X.; Wang Q.Y.; Dong H.; Lee M.Y.; Kang C.; Yuan Z.; Shi P.Y.; Characterization of dengue virus NS4A and NS4B protein interaction. J Virol  2015,89(7),3455-3470","journal-title":"J Virol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1128\/jvi.67.4.2327-2335.1993","volume":"67","author":"Lin C.","year":"1993","unstructured":"Lin C.; Amberg S.M.; Chambers T.J.; Rice C.M.; Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A\/4B signalase site. J Virol  1993,67(4),2327-2335","journal-title":"J Virol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bcp.2018.04.008","volume":"154","author":"Reddy S.B.G.","year":"2018","unstructured":"Reddy S.B.G.; Chin W-X.; Shivananju N.S.; Dengue virus NS2 and NS4: Minor proteins, mammoth roles. Biochem Pharmacol  2018,154,54-63","journal-title":"Biochem Pharmacol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"11274","DOI":"10.1128\/JVI.05864-11","volume":"85","author":"Ambrose R.L.","year":"2011","unstructured":"Ambrose R.L.; Mackenzie J.M.; A conserved peptide in West Nile virus NS4A protein contributes to proteolytic processing and is essential for replication. J Virol  2011,85(21),11274-11282","journal-title":"J Virol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"10268","DOI":"10.1128\/JVI.79.16.10268-10277.2005","volume":"79","author":"Wu J.","year":"2005","unstructured":"Wu J.; Bera A.K.; Kuhn R.J.; Smith J.L.; Structure of the flavivirus helicase: Implications for catalytic activity, protein interactions, and proteolytic processing. J Virol  2005,79(16),10268-10277","journal-title":"J Virol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.virol.2007.12.018","volume":"373","author":"Yamashita T.","year":"2008","unstructured":"Yamashita T.; Unno H.; Mori Y.; Tani H.; Moriishi K.; Takamizawa A.; Agoh M.; Tsukihara T.; Matsuura Y.; Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase\/nucleoside triphosphatase at a resolution of 1.8 \u00c5. Virology  2008,373(2),426-436","journal-title":"Virology"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.antiviral.2018.05.003","volume":"155","author":"Nobori H.","year":"2018","unstructured":"Nobori H.; Toba S.; Yoshida R.; Hall W.W.; Orba Y.; Sawa H.; Sato A.; Identification of compound-B, a novel anti-dengue virus agent targeting the non-structural protein 4A. Antiviral Res  2018,155,60-66","journal-title":"Antiviral Res"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"8854","DOI":"10.1074\/jbc.M512697200","volume":"281","author":"Miller S.","year":"2006","unstructured":"Miller S.; Sparacio S.; Bartenschlager R.; Subcellular localization and membrane topology of the dengue virus type 2 non-structural protein 4B. J Biol Chem  2006,281(13),8854-8863","journal-title":"J Biol Chem"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"12247","DOI":"10.1002\/ange.201606609","volume":"128","author":"Li Y.","year":"2016","unstructured":"Li Y.; Wong Y.L.; Lee M.Y.; Li Q.; Wang Q.Y.; Lescar J.; Shi P.Y.; Kang C.; Secondary structure and membrane topology of the full-length dengue virus NS4B in micelles. Angew Chem  2016,128(39),12247-12251","journal-title":"Angew Chem"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1099\/vir.0.81844-0","volume":"87","author":"Umareddy I.","year":"2006","unstructured":"Umareddy I.; Chao A.; Sampath A.; Gu F.; Vasudevan S.G.; Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA. J Gen Virol  2006,87(9),2605-2614","journal-title":"J Gen Virol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1128\/JVI.02782-13","volume":"88","author":"Zou J.","year":"2014","unstructured":"Zou J.; Xie X.; Lee L.T.; Chandrasekaran R.; Reynaud A.; Yap L.; Wang Q.Y.; Dong H.; Kang C.; Yuan Z.; Lescar J.; Shi P.Y.; Dimerization of flavivirus NS4B protein. J Virol  2014,88(6),3379-3391","journal-title":"J Virol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/rmv.1835","volume":"25","author":"Zmurko J.","year":"2015","unstructured":"Zmurko J.; Neyts J.; Dallmeier K.; Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention. Rev Med Virol  2015,25(4),205-223","journal-title":"Rev Med Virol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.virol.2008.11.003","volume":"384","author":"Zou G.","year":"2009","unstructured":"Zou G.; Puig-Basagoiti F.; Zhang B.; Qing M.; Chen L.; Pankiewicz K.W.; Felczak K.; Yuan Z.; Shi P.Y.; A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor. Virology  2009,384(1),242-252","journal-title":"Virology"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/cmdc.201300505","volume":"9","author":"Wang P.","year":"2014","unstructured":"Wang P.; Li L.F.; Wang Q.Y.; Shang L.Q.; Shi P.Y.; Yin Z.; Anti-dengue-virus activity and structure-activity relationship studies of lycorine derivatives. ChemMedChem  2014,9(7),1522-1533","journal-title":"ChemMedChem"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"11183","DOI":"10.1128\/JVI.05468-11","volume":"85","author":"Xie X.","year":"2011","unstructured":"Xie X.; Wang Q.Y.; Xu H.Y.; Qing M.; Kramer L.; Yuan Z.; Shi P.Y.; Inhibition of dengue virus by targeting viral NS4B protein. J Virol  2011,85(21),11183-11195","journal-title":"J Virol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.antiviral.2013.05.011","volume":"99","author":"van Cleef K.W.R.","year":"2013","unstructured":"van Cleef K.W.R.; Overheul G.J.; Thomassen M.C.; Kaptein S.J.F.; Davidson A.D.; Jacobs M.; Neyts J.; van Kuppeveld F.J.M.; van Rij R.P.; Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication. Antiviral Res  2013,99(2),165-171","journal-title":"Antiviral Res"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"8233","DOI":"10.1128\/JVI.00855-15","volume":"89","author":"Wang Q.Y.","year":"2015","unstructured":"Wang Q.Y.; Dong H.; Zou B.; Karuna R.; Wan K.F.; Zou J.; Susila A.; Yip A.; Shan C.; Yeo K.L.; Xu H.; Ding M.; Chan W.L.; Gu F.; Seah P.G.; Liu W.; Lakshminarayana S.B.; Kang C.; Lescar J.; Blasco F.; Smith P.W.; Shi P.Y.; Discovery of dengue virus NS4B inhibitors. J Virol  2015,89(16),8233-8244","journal-title":"J Virol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1128\/AAC.02462-15","volume":"60","author":"van Cleef K.W.R.","year":"2016","unstructured":"van Cleef K.W.R.; Overheul G.J.; Thomassen M.C.; Marjakangas J.M.; van Rij R.P.; Escape mutations in NS4B render dengue virus insensitive to the antiviral activity of the paracetamol metabolite AM404. Antimicrob Agents Chemother  2016,60(4),2554-2557","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.1128\/JVI.00665-11","volume":"85","author":"Grant D.","year":"2011","unstructured":"Grant D.; Tan G.K.; Qing M.; Ng J.K.W.; Yip A.; Zou G.; Xie X.; Yuan Z.; Schreiber M.J.; Schul W.; Shi P.Y.; Alonso S.; A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis. J Virol  2011,85(15),7775-7787","journal-title":"J Virol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1021\/ml500521r","volume":"6","author":"Zou B.","year":"2015","unstructured":"Zou B.; Chan W.L.; Ding M.; Leong S.Y.; Nilar S.; Seah P.G.; Liu W.; Karuna R.; Blasco F.; Yip A.; Chao A.; Susila A.; Dong H.; Wang Q.Y.; Xu H.Y.; Chan K.; Wan K.F.; Gu F.; Diagana T.T.; Wagner T.; Dix I.; Shi P.Y.; Smith P.W.; Lead optimization of spiropyrazolopyridones: A new and potent class of dengue virus inhibitors. ACS Med Chem Lett  2015,6(3),344-348","journal-title":"ACS Med Chem Lett"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.bmcl.2017.02.005","volume":"27","author":"Kounde C.S.","year":"2017","unstructured":"Kounde C.S.; Yeo H.Q.; Wang Q.Y.; Wan K.F.; Dong H.; Karuna R.; Dix I.; Wagner T.; Zou B.; Simon O.; Bonamy G.M.C.; Yeung B.K.S.; Yokokawa F.; Discovery of 2-oxopiperazine dengue inhibitors by scaffold morphing of a phenotypic high-throughput screening hit. Bioorg Med Chem Lett  2017,27(6),1385-1389","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.antiviral.2017.10.011","volume":"147","author":"Hernandez-Morales I.","year":"2017","unstructured":"Hernandez-Morales I.; Geluykens P.; Clynhens M.; Strijbos R.; Goethals O.; Megens S.; Verheyen N.; Last S.; McGowan D.; Coesemans E.; De Boeck B.; Stoops B.; Devogelaere B.; Pauwels F.; Vandyck K.; Berke J.M.; Raboisson P.; Simmen K.; Lory P.; Van Loock M.; Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library. Antiviral Res  2017,147,149-158","journal-title":"Antiviral Res"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-3527(09)74002-3","volume":"74","author":"Davidson A.D.","year":"2009","unstructured":"Davidson A.D.; Chapter 2. New insights into flavivirus nonstructural protein 5. Adv Virus Res  2009,74,41-101","journal-title":"Adv Virus Res"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.antiviral.2008.06.007","volume":"80","author":"Malet H.","year":"2008","unstructured":"Malet H.; Mass\u00e9 N.; Selisko B.; Romette J.L.; Alvarez K.; Guillemot J.C.; Tolou H.; Yap T.L.; Vasudevan S.G.; Lescar J.; Canard B.; The flavivirus polymerase as a target for drug discovery. Antiviral Res  2008,80(1),23-35","journal-title":"Antiviral Res"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"31105","DOI":"10.1074\/jbc.M113.508606","volume":"288","author":"Lim S.P.","year":"2013","unstructured":"Lim S.P.; Koh J.H.K.; Seh C.C.; Liew C.W.; Davidson A.D.; Chua L.S.; Chandrasekaran R.; Cornvik T.C.; Shi P.Y.; Lescar J.; A crystal structure of the dengue virus non-structural protein 5 (NS5) polymerase delineates interdomain amino acid residues that enhance its thermostability and de novo initiation activities. J Biol Chem  2013,288(43),31105-31114","journal-title":"J Biol Chem"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"8362","DOI":"10.1128\/JVI.00814-06","volume":"80","author":"Ray D.","year":"2006","unstructured":"Ray D.; Shah A.; Tilgner M.; Guo Y.; Zhao Y.; Dong H.; Deas T.S.; Zhou Y.; Li H.; Shi P.Y.; West Nile virus 5\u2032-cap structure is formed by sequential guanine N-7 and ribose 2\u2032-O methylations by nonstructural protein 5. J Virol  2006,80(17),8362-8370","journal-title":"J Virol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1128\/JVI.02704-06","volume":"81","author":"Zhou Y.","year":"2007","unstructured":"Zhou Y.; Ray D.; Zhao Y.; Dong H.; Ren S.; Li Z.; Guo Y.; Bernard K.A.; Shi P.Y.; Li H.; Structure and function of flavivirus NS5 methyltransferase. J Virol  2007,81(8),3891-3903","journal-title":"J Virol"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/v9040091","volume":"9","author":"El Sahili A.","year":"2017","unstructured":"El Sahili A.; Lescar J.; Dengue virus non-structural protein 5. Viruses  2017,9(4),91","journal-title":"Viruses"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.virol.2010.06.039","volume":"405","author":"Dong H.","year":"2010","unstructured":"Dong H.; Chang D.C.; Xie X.; Toh Y.X.; Chung K.Y.; Zou G.; Lescar J.; Lim S.P.; Shi P.Y.; Biochemical and genetic characterization of dengue virus methyltransferase. Virology  2010,405(2),568-578","journal-title":"Virology"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ni.1979","volume":"12","author":"Z\u00fcst R.","year":"2011","unstructured":"Z\u00fcst R.; Cervantes-Barragan L.; Habjan M.; Maier R.; Neuman B.W.; Ziebuhr J.; Szretter K.J.; Baker S.C.; Barchet W.; Diamond M.S.; Siddell S.G.; Ludewig B.; Thiel V.; Ribose 2\u2032-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol  2011,12(2),137-143","journal-title":"Nat Immunol"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"e1003521","DOI":"10.1371\/journal.ppat.1003521","volume":"9","author":"Z\u00fcst R.","year":"2013","unstructured":"Z\u00fcst R.; Dong H.; Li X.F.; Chang D.C.; Zhang B.; Balakrishnan T.; Toh Y.X.; Jiang T.; Li S.H.; Deng Y.Q.; Ellis B.R.; Ellis E.M.; Poidinger M.; Zolezzi F.; Qin C.F.; Shi P.Y.; Fink K.; Rational design of a live attenuated dengue vaccine: 2\u2032-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques. PLoS Pathog  2013,9(8),e1003521","journal-title":"PLoS Pathog"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1099\/vir.0.82757-0","volume":"88","author":"Assenberg R.","year":"2007","unstructured":"Assenberg R.; Ren J.; Verma A.; Walter T.S.; Alderton D.; Hurrelbrink R.J.; Fuller S.D.; Bressanelli S.; Owens R.J.; Stuart D.I.; Grimes J.M.; Crystal structure of the murray valley encephalitis virus NS5 methyltransferase domain in complex with cap analogues. J Gen Virol  2007,88(8),2228-2236","journal-title":"J Gen Virol"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jmb.2008.10.028","volume":"385","author":"Bollati M.","year":"2009","unstructured":"Bollati M.; Milani M.; Mastrangelo E.; Ricagno S.; Tedeschi G.; Nonnis S.; Decroly E.; Selisko B.; de Lamballerie X.; Coutard B.; Canard B.; Bolognesi M.; Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain: Implications for RNA-capping mechanisms in Flavivirus. J Mol Biol  2009,385(1),140-152","journal-title":"J Mol Biol"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1093\/emboj\/21.11.2757","volume":"21","author":"Egloff M.P.","year":"2002","unstructured":"Egloff M.P.; Benarroch D.; Selisko B.; Romette J-L.; Canard B.; An RNA cap (nucleoside-2\u2032-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J  2002,21(11),2757-2768","journal-title":"EMBO J"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.jmb.2008.11.058","volume":"385","author":"Geiss B.J.","year":"2009","unstructured":"Geiss B.J.; Thompson A.A.; Andrews A.J.; Sons R.L.; Gari H.H.; Keenan S.M.; Peersen O.B.; Analysis of flavivirus NS5 methyltransferase cap binding. J Mol Biol  2009,385(5),1643-1654","journal-title":"J Mol Biol"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1107\/S0907444909017260","volume":"65","author":"Jansson A.M.","year":"2009","unstructured":"Jansson A.M.; Jakobsson E.; Johansson P.; Lantez V.; Coutard B.; de Lamballerie X.; Unge T.; Jones T.A.; Structure of the methyltransferase domain from the modoc virus, a flavivirus with no known vector. Acta Crystallogr D Biol Crystallogr  2009,65(8),796-803","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1110\/ps.072758107","volume":"16","author":"Mastrangelo E.","year":"2007","unstructured":"Mastrangelo E.; Bollati M.; Milani M.; Selisko B.; Peyrane F.; Canard B.; Grard G.; de Lamballerie X.; Bolognesi M.; Structural bases for substrate recognition and activity in Meaban virus nucleoside-2\u2032-O-methyltransferase. Protein Sci  2007,16(6),1133-1145","journal-title":"Protein Sci"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1074\/jbc.M110.179184","volume":"286","author":"Lim S.P.","year":"2011","unstructured":"Lim S.P.; Sonntag L.S.; Noble C.; Nilar S.H.; Ng R.H.; Zou G.; Monaghan P.; Chung K.Y.; Dong H.; Liu B.; Bodenreider C.; Lee G.; Ding M.; Chan W.L.; Wang G.; Jian Y.L.; Chao A.T.; Lescar J.; Yin Z.; Vedananda T.R.; Keller T.H.; Shi P.Y.; Small molecule inhibitors that selectively block dengue virus methyltransferase. J Biol Chem  2011,286(8),6233-6240","journal-title":"J Biol Chem"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"e12836","DOI":"10.1371\/journal.pone.0012836","volume":"5","author":"Yap L.J.","year":"2010","unstructured":"Yap L.J.; Luo D.; Chung K.Y.; Lim S.P.; Bodenreider C.; Noble C.; Shi P.Y.; Lescar J.; Crystal structure of the dengue virus methyltransferase bound to a 5\u2032-capped octameric RNA. PLoS One  2010,5(9),e12836","journal-title":"PLoS One"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"e25795","DOI":"10.1371\/journal.pone.0025795","volume":"6","author":"Henderson B.R.","year":"2011","unstructured":"Henderson B.R.; Saeedi B.J.; Campagnola G.; Geiss B.J.; Analysis of RNA binding by the dengue virus NS5 RNA capping enzyme. PLoS One  2011,6(10),e25795","journal-title":"PLoS One"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"11642","DOI":"10.1093\/nar\/gku666","volume":"42","author":"Potisopon S.","year":"2014","unstructured":"Potisopon S.; Priet S.; Collet A.; Decroly E.; Canard B.; Selisko B.; The methyltransferase domain of dengue virus protein NS5 ensures efficient RNA synthesis initiation and elongation by the polymerase domain. Nucleic Acids Res  2014,42(18),11642-11656","journal-title":"Nucleic Acids Res"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.antiviral.2008.08.005","volume":"80","author":"Lim S.","year":"2008","unstructured":"Lim S.; Wen D.; Yap T.; Yan C.; Lescar J.; Vasudevan S.; A scintillation proximity assay for dengue virus NS5 2\u2032-O-methyltransferase-kinetic and inhibition analyses. Antiviral Res  2008,80(3),360-369","journal-title":"Antiviral Res"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1099\/vir.0.015511-0","volume":"91","author":"Selisko B.","year":"2010","unstructured":"Selisko B.; Peyrane F.F.; Canard B.; Alvarez K.; Decroly E.; Biochemical characterization of the (nucleoside-2'O)-methyltransferase activity of dengue virus protein NS5 using purified capped RNA oligonucleotides 7MeGpppACn and GpppACn. J Gen Virol  2010,91(1),112-121","journal-title":"J Gen Virol"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.virol.2010.03.011","volume":"402","author":"Chung K.Y.","year":"2010","unstructured":"Chung K.Y.; Dong H.; Chao A.T.; Shi P.Y.; Lescar J.; Lim S.P.; Higher catalytic efficiency of N-7-methylation is responsible for processive N-7 and 2\u2032-O methyltransferase activity in dengue virus. Virology  2010,402(1),52-60","journal-title":"Virology"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.antiviral.2013.06.001","volume":"99","author":"Barral K.","year":"2013","unstructured":"Barral K.; Sallamand C.; Petzold C.; Coutard B.; Collet A.; Thillier Y.; Zimmermann J.; Vasseur J.J.; Canard B.; Rohayem J.; Debart F.; Decroly E.; Development of specific dengue virus 2\u2032-O- and N7-methyltransferase assays for antiviral drug screening. Antiviral Res  2013,99(3),292-300","journal-title":"Antiviral Res"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"32586","DOI":"10.1074\/jbc.M110.129197","volume":"285","author":"Dong H.","year":"2010","unstructured":"Dong H.; Liu L.; Zou G.; Zhao Y.; Li Z.; Lim S.P.; Shi P.Y.; Li H.; Structural and functional analyses of a conserved hydrophobic pocket of flavivirus methyltransferase. J Biol Chem  2010,285(42),32586-32595","journal-title":"J Biol Chem"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.antiviral.2014.09.003","volume":"111","author":"Noble C.G.","year":"2014","unstructured":"Noble C.G.; Li S.H.; Dong H.; Chew S.H.; Shi P.Y.; Crystal structure of dengue virus methyltransferase without S-adenosyl-L-methionine. Antiviral Res  2014,111,78-81","journal-title":"Antiviral Res"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/pro.2594","volume":"24","author":"Brecher M.B.","year":"2015","unstructured":"Brecher M.B.; Li Z.; Zhang J.; Chen H.; Lin Q.; Liu B.; Li H.; Refolding of a fully functional flavivirus methyltransferase revealed that S-adenosyl methionine but not S-adenosyl homocysteine is copurified with flavivirus methyltransferase. Protein Sci  2015,24(1),117-128","journal-title":"Protein Sci"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.ejmech.2017.10.064","volume":"143","author":"Cannalire R.","year":"2018","unstructured":"Cannalire R.; Tarantino D.; Astolfi A.; Barreca M.L.; Sabatini S.; Massari S.; Tabarrini O.; Milani M.; Querat G.; Mastrangelo E.; Manfroni G.; Cecchetti V.; Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase. Eur J Med Chem  2018,143,1667-1676","journal-title":"Eur J Med Chem"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/cmdc.201800178","volume":"13","author":"Kaptein S.J.F.","year":"2018","unstructured":"Kaptein S.J.F.; Vincetti P.; Crespan E.; Rivera J.I.A.; Costantino G.; Maga G.; Neyts J.; Radi M.; Identification of broad-spectrum dengue\/zika virus replication inhibitors by functionalization of quinoline and 2,6-diaminopurine scaffolds. ChemMedChem  2018,13(14),1371-1376","journal-title":"ChemMedChem"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejmech.2015.12.046","volume":"109","author":"Benmansour F.","year":"2016","unstructured":"Benmansour F.; Eydoux C.; Querat G.; de Lamballerie X.; Canard B.; Alvarez K.; Guillemot J.C.; Barral K.; Novel 2-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,3,4-oxadiazole and 3-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,2,4-oxadiazole derivatives as dengue virus inhibitors targeting NS5 polymerase. Eur J Med Chem  2016,109,146-156","journal-title":"Eur J Med Chem"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1128\/AAC.02203-15","volume":"60","author":"Xu H.T.","year":"2016","unstructured":"Xu H.T.; Colby-Germinario S.P.; Hassounah S.; Quashie P.K.; Han Y.; Oliveira M.; Stranix B.R.; Wainberg M.A.; Identification of a pyridoxine-derived small-molecule inhibitor targeting dengue virus RNA-dependent RNA polymerase. Antimicrob Agents Chemother  2016,60(1),600-608","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1021\/acs.jmedchem.6b00143","volume":"59","author":"Yokokawa F.","year":"2016","unstructured":"Yokokawa F.; Nilar S.; Noble C.G.; Lim S.P.; Rao R.; Tania S.; Wang G.; Lee G.; Hunziker J.; Karuna R.; Manjunatha U.; Shi P.Y.; Smith P.W.; Discovery of potent non-nucleoside inhibitors of dengue viral RNA-dependent RNA polymerase from a fragment hit using structure-based drug design. J Med Chem  2016,59(8),3935-3952","journal-title":"J Med Chem"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"e1005737","DOI":"10.1371\/journal.ppat.1005737","volume":"12","author":"Lim S.P.","year":"2016","unstructured":"Lim S.P.; Noble C.G.; Seh C.C.; Soh T.S.; El Sahili A.; Chan G.K.Y.; Lescar J.; Arora R.; Benson T.; Nilar S.; Manjunatha U.; Wan K.F.; Dong H.; Xie X.; Shi P.Y.; Yokokawa F.; Potent allosteric dengue virus NS5 polymerase inhibitors: Mechanism of action and resistance profiling. PLoS Pathog  2016,12(8),e1005737","journal-title":"PLoS Pathog"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1038\/s41598-017-04449-3","volume":"7","author":"Madhvi A.","year":"2017","unstructured":"Madhvi A.; Hingane S.; Srivastav R.; Joshi N.; Subramani C.; Muthumohan R.; Khasa R.; Varshney S.; Kalia M.; Vrati S.; Surjit M.; Ranjith-Kumar C.T.; A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound. Sci Rep  2017,7(1),5816","journal-title":"Sci Rep"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.bmcl.2018.04.069","volume":"28","author":"Wang G.","year":"2018","unstructured":"Wang G.; Lim S.P.; Chen Y.L.; Hunziker J.; Rao R.; Gu F.; Seh C.C.; Ghafar N.A.; Xu H.; Chan K.; Lin X.; Saunders O.L.; Fenaux M.; Zhong W.; Shi P.Y.; Yokokawa F.; Structure-activity relationship of uridine-based nucleoside phosphoramidate prodrugs for inhibition of dengue virus RNA-dependent RNA polymerase. Bioorg Med Chem Lett  2018,28(13),2324-2327","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=177","first-page":"286","volume":"8","author":"Coulerie P.","year":"2014","unstructured":"Coulerie P.; Maciuk A.; Eydoux C.; Hnawia E.; Lebouvier N.; Figad\u00e8re B.; Guillemot J-C.; Nour M.; New inhibitors of the DENV-NS 5 RdRp from carpolepis laurifolia as potential antiviral drugs for dengue treatment. Rec Nat Prod  2014,8(3),286","journal-title":"Rec Nat Prod"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.antiviral.2016.09.007","volume":"134","author":"Tarantino D.","year":"2016","unstructured":"Tarantino D.; Cannalire R.; Mastrangelo E.; Croci R.; Querat G.; Barreca M.L.; Bolognesi M.; Manfroni G.; Cecchetti V.; Milani M.; Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor. Antiviral Res  2016,134,226-235","journal-title":"Antiviral Res"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejphar.2017.12.029","volume":"821","author":"Yao X.","year":"2018","unstructured":"Yao X.; Ling Y.; Guo S.; He S.; Wang J.; Zhang Q.; Wu W.; Zou M.; Zhang T.; Nandakumar K.S.; Chen X.; Liu S.; Inhibition of dengue viral infection by diasarone-I is associated with 2'O methyltransferase of NS5. Eur J Pharmacol  2018,821,11-20","journal-title":"Eur J Pharmacol"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1021\/acs.jmedchem.5b00327","volume":"58","author":"Vernekar S.K.V.","year":"2015","unstructured":"Vernekar S.K.V.; Qiu L.; Zhang J.; Kankanala J.; Li H.; Geraghty R.J.; Wang Z.; 5\u2032-Silylated 3\u2032-1,2,3-triazolyl thymidine analogues as inhibitors of west nile virus and dengue virus. J Med Chem  2015,58(9),4016-4028","journal-title":"J Med Chem"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ejmech.2016.10.007","volume":"125","author":"Benmansour F.","year":"2017","unstructured":"Benmansour F.; Trist I.; Coutard B.; Decroly E.; Querat G.; Brancale A.; Barral K.; Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design. Eur J Med Chem  2017,125,865-880","journal-title":"Eur J Med Chem"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"e0130062","DOI":"10.1371\/journal.pone.0130062","volume":"10","author":"Brecher M.","year":"2015","unstructured":"Brecher M.; Chen H.; Liu B.; Banavali N.K.; Jones S.A.; Zhang J.; Li Z.; Kramer L.D.; Li H.; Novel broad spectrum inhibitors targeting the flavivirus methyltransferase. PLoS One  2015,10(6),e0130062","journal-title":"PLoS One"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/13543784.2016.1201063","volume":"25","author":"Beesetti H.","year":"2016","unstructured":"Beesetti H.; Khanna N.; Swaminathan S.; Investigational drugs in early development for treating dengue infection. Expert Opin Investig Drugs  2016,25(9),1059-1069","journal-title":"Expert Opin Investig Drugs"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230918110144","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/221197\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230918110144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T10:01:28Z","timestamp":1713952888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/221197\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":183,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867331666230918110144","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}